probe at a concentration of 0.02 kg/A1 of hybridization mixture as described (8) . The slides were exposed for 7 d.
Results
Isolation of the LAM-1 cDNA Clone. B cell-specific cDNAs were isolated from a human tonsil cDNA library using differential hybridization with labeled cDNAs derived from either B cell (RAJI) RNA or T cell (HSB-2) RNA (5) . One of the 261 RAJI+ HSB2 -cDNA clones isolated, B125, contained a 1 .9-kb cDNA insert that hybridized with a 2.4-kb species found in several B cell lines (5) . However, B125 did not hybridize with any of the other RAJI+ HSB2 -clones or with mRNA from several T cell lines. The B125 cDNA clone was characterized by restriction mapping and nucleotide sequence determination . A near full-length 2.3-kb cDNA that hybridized with B125 was isolated, sequenced, and termed pLAM-1 ( Fig. 1 A) . This clone contained a 1,181-bp open reading frame that could encode a protein of 372 amino acids (Fig . 1 C) .
The amino acid sequence of LAM-1 predicted a structure typical of a membrane glycoprotein . Two potential translation initiation sites were found at nucleotide positions 53 and 92 . The second initiation site confirmed best to the consensus sequence for optimal initiation (A/G)CCAUG (9) and was followed by a hydrophobic region of 27 amino acids that may represent a signal peptide. The algorithm of von Heijne (10) predicted that the most probable NH2 terminus of the mature protein would be the Trp at amino acid position 52 (Fig. 1 C) . The LAM-1 sequence contained a second hydrophobic region between amino acids 346 and 368 that may be a transmembrane region . The predicted mature LAM-1 protein would have an extracellular region of -294 amino acids containing seven potential N-linked carbohydrate attachment sites. LAM-1 would have a cytoplasmic tail of 17 amino acids containing eight basic and one acidic residues . The two cytoplasmic Ser residues may serve as substrates for phosphorylation since protein kinase C phosphorylates Ser residues that are on the COOH-terminal side of several basic residues . These results suggest that the processed LAM-1 protein would have an Mr of at least 50,000 .
LAM-1 Contains Multiple Distinct Domains. The proposed extracellular region of LAM-1 contained a high number of Cys residues (7%) with a general structure, as depicted in Fig. 1 B. The first 157 amino acids of the protein were homologous with the low affinity receptor for IgE (11) , the asialoglycoprotein receptor (12) , and several other carbohydrate-binding proteins (13) (14) (15) (16) (Fig. 2 A) . Although the sequence homologies were <30%, all the invariant residues found in animal lectin carbohydraterecognition domains were conserved (17) . The next domain of 36 amino acids was homologous (36-39%) with epidermal growth factor (EGF) (18) and the EGFlike repeat units found in factor IX (19) and fibroblast proteoglycan core protein (15) (Fig . 2 B) . Immediately after these domains were two tandem domains of 62 amino acids each that were homologous with the short consensus repeat units (SCR) that comprise the IL-2-R (20), factor XIII (21), and many C3/C4 binding proteins (22, 23) (Fig . 2 C) . In contrast to all of the previously described SCR that contain four conserved Cys residues, these two SCR possessed six Cys residues . A 15-amino acid spacer preceded the putative transmembrane domain.
Homology ofLAM-1 with mLHR, SLAM-1, and GMP-140. LAM-1 shares a 77% amino acid sequence homology with the mouse LHR (Fig. 3 ). Significant homologies of nucleotide sequences outside of the putative coding regions were not found. The leader sequence of mLHR shares a 63 % amino acid sequence homology with LAM-1, while the lectin domains share an 83% homology. The lectin domain of LAM-1 shares a 67 and 61% sequence homology with GMP-140 and ELAM-1, respec-
Homology of LAM-1
with the mouse lymphocyte RDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPN 133 homing receptor (1) .
amino acids are represented (-) . NKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINNYTCNCD 196 Numbers to the right indicate  ---S-----------ER-S----------R------------G--N-R-----T---H--I-- the amino acid residue positions shown in Fig . 1 C . The arrow VGYYGPQCQFVIQCEPLEAPELGTMDCTHPLGNFNFNSQCAFSCSEGTNLTGIEETTCEPFGN 259 indicates the predicted NH2
terminus of LAM-1 and the de-WSSPEPTCQVIQCEPLSAPDLGIMNCSHPLASFSFTSACTFICSEGTELIGKKKTICESSGIW 322
termined NH2 terminus of ------I---V-----E--E--T-D-I---GN---Q-K-A-N----R--L-TAE-Q-GA--N-
mLHR . The underlined region SNPSPICQKLDKSFSMIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKRSMNDPY 385 indicates the putative transmem-
_S_E----ETNR--_((__-___-_____. .__--------QER-D---
brane region .
tively. The EGF domain of LAM-1 shares an 80, 66, and 63 % homology with mLHR, ELAM-1, and GMP-140 domains, respectively. SCR-1 and SCR-2 of LAM-1 are 74 and 61% homologous with the two identical SCR domains of mLHR . Most interesting is that the putative transmembrane domains of LAM-1 and mLHR are 95% homologous, while the cytoplasmic tails are 78% homologous . The transmembrane and cytoplasmic domains of LAM-1 share little sequence homology with the corresponding domains in ELAM-1 and GMP-140.
Expression ofLAM-1 mRNA . Northern analysis revealed that LAM-1 hybridized strongly to a 2.6-kb RNA species and weakly to a 1 .7-kb RNA species in poly(A)' RNA isolated from the B cell lines Raji, SB (Fig . 4 A) , Laz-509, and GK-5 (data not shown) . The 1 .7-kb RNA species may result from alternate use of the potential poly(A) signal sequence, ATATAAA, at position 1493 ( Fig . 1 C) , which serves as , and an erythroleukemic cell line (K-562) did not hybridize with LAM-1, suggesting that expression ofthis gene was preferentially associated with B lymphoblastoid cell lines (data not shown) . However, analysis of mRNA isolated from blood lymphocytes and purified blood T cells revealed that LAM-1 mRNA was readily detected in T cells and increased after mitogen stimulation (Fig . 4 B) . Both the 2.6-and 1 .7-kb RNA species that hybridized with pLAM-1 were expressed by T cells. Low levels of LAM-1 mRNA were detected in some monocyte preparations, but not in others, suggesting that LAM-1 may also be expressed by monocytes at amounts far below those observed in T lymphocytes. Alternatively, low numbers oflymphocytes (<2 %) contaminating the monocyte preparations may account for this variability. Treatment of monocytes with Bryostatin 1 or LPS did not induce LAM-1 mRNA, and LAM-1 mRNA was not detected in malignant cells from two patients with chronic myelogenous leukemia (data not shown) . In addition, a human fibroblast cell line (Wi-38 and Wi-38 stimulated with LPS) and primary cultures of human fibroblasts transfected with the EJ-ras oncogene did not express detectable LAM-1 mRNA. Human epithelial keratinocytes, untreated or cultured with LPS or TNF, also failed to express detectable LAM-1 mRNA.
Chromosome Location ofthe LAM-1 Gene. The LAM-1 gene was localized on human metaphase chromosomes by in situ hybridization using the LAM-1 cDNA clone as a labeled probe. A total of 181 sites of hybridization in 48 metaphase cells were scored (Fig. 5 a) . Of the 181 sites of hybridization, 48 (27%) were located between bands q22 and q25 of the long arm of chromosome 1. There was no significant hybridization to other chromosomes (Fig. 5 a) . The largest number of grains on chromosome 1 were located at bands q23 and q24, with significant hybridization to band q25 (Fig. 5 b) .
Discussion
The generation of genes by the assembly of functionally independent domains has occurred frequently as new genes evolved to encode proteins with new functions. However, LAM-1 combines previously unrelated domains found in three distinct families of molecules: animal lectins, growth factors, and C3/C4 binding proteins. The LAM-1 lectin-like domain has homology with mammalian lectins specific for glycans with terminal galactosyl, N-acetylglucosaminyl, and mannosyl residues (17) , and homology with the lectin-like domain of the low affinity Fc receptor for IgE (11) . Most animal carbohydrate-binding receptors, however, differ from LAM-1 since their COOH terminus contains the lectin domain and is on the outside of the membrane, while their NH2 terminus is inside the cell (17) . An exception, like LAM-1, is the galactose-binding protein from fly hemolymph that has the lectin domain at the NH2-terminal end of the protein (16) . Although the carbohydratebinding domain in fly hemolymph lectin diverged a considerable time ago from human LAM-1, it is homologous (23%) with the LAM-1 lectin-like domain (Fig . 2 A) . Interestingly, it has been proposed that the lectin isolated from fly hemolymph may be involved in a primitive immune response (24) . The homology of another LAM-1 domain with proteins that contain EGFlike sequences, such as blood clotting factors, suggests that this domain could also interact with other proteins (19) . EGFlike repeat units are also found injuxtaposition with the lectin domain of fibroblast proteoglycan core protein, suggesting that this protein and LAM-1 may be evolutionarily related (15) . The SCR domains may also have receptor function, since the extracellular domains ofreceptors for many complement components and IL-2 are composed of SCR domains (20) (21) (22) (23) .
LAM-1 is a new member of a family of recently described cellular adhesion proteins (1) (2) (3) . This family includes the mouse LHR that has a 77% amino acid sequence homology with LAM-1 (Fig. 3) . Northern analysis of LAM-1 expression demonstrated a predominantly lymphoid distribution in humans (Fig. 4) that is also similar to the cell surface expression of the mLHR (1) . Since pretreatment of mouse lymphocytes with specific polysaccharides inhibits their adherence to high endothelial venules in lymph nodes, the lectin-like domain of LAM-1 may also function in the adherence oflymphocytes to endothelial cells (25) . The lectin-like and EGF like domains of LAM-1 and mLHR shared considerable homology (83-80%), but the area of highest homology (95%) was found in the putative transmembrane region, suggesting that these domains may be most critical to the function ofLAM-1 and mLHR. Although LAM-1 and mLHR are structurally homologous, it is not known whether LAM-1 functions as the LHR in man . However, preliminary studies demonstrate that the cell lines that express high levels of LAM-1 mRNA (Fig. 4) bind to human high endothelial venules, while most of those that do not express LAM-1 mRNA do not bind (A. Freedman and T F. Tedder, unpublished observations) . Therefore, it is possible that LAM-1 serves a function in man similar to that of the LHR in mouse .
Other members of this new adhesion molecule family that are homologous with LAM-1 include the inducible ELAM-1, which is expressed on the surface of cytokinetreated endothelial cells (2) . This molecule is thought to be responsible for the accumulation of blood leukocytes at sites of inflammation by mediating the adhesion of cells to the vascular lining . LAM-1 and ELAM-1 exhibit homologous structural features, including the presence of lectin-and EGFlike domains followed by SCR domains that contain six conserved Cys residues. In addition, a granule membrane protein found in platelets and endothelial cells, termed GMP-140, is also homologous with LAM-1 in that it contains lectin, EGF, and SCR domains (3) . These proteins and LAM-1 thus appear to define a new family of homologous structures that are each expressed by different human cell lineages.
The LAM-1 gene is located on human chromosome 1 at band q23-25 (Fig. 5) . The gene for GMP-140 has also been mapped to chromosome 1 q21-24 (3, McEver, R., G. Johnston, and M . Le Beau, personal communication) . These findings suggest that a cluster of "adhesion molecule" loci may exist on the long arm of chromosome 1 in the region q21-25, which contains at least two of the three members of this human gene family. This locus is distinct from the "complement receptor" locus at band 1832, which encodes the SCR containing proteins, CR1, CR2, C4-binding protein, and factor H (26) . The finding that two of these new genes map to the same band of human chromosome 1, in addition to their common structural motif, further demonstrates that these proteins are members of a closely related family of proteins . Summary A cDNA encoding a new human lymphocyte cell surface molecule has been isolated and shown to identify a fourth member of a recently discovered family of adhesion proteins . This lymphocyte-associated molecule (LAM-1) is uniquely composed ofmultiple distinct domains, one domain homologous with animal lectins, one homologous with epidermal growth factor, and two short consensus repeat units similar to those found in C3/C4 binding proteins . This cDNA clone hybridized with RNAs found in B cell lines and T lymphocytes, but not with RNA from other cell types . The amino acid sequence of LAM-1 is 77% homologous with the sequence of the mouse lymphocyte homing receptor, suggesting that LAM-1 may function in human lymphocyte adhesion. The LAM-1 gene is located on chromosome lg23-25, as is another member ofthis adhesion family, suggesting that this new family of proteins may be encoded by a cluster of "adhesion protein" loci.
